ABSTRACT
Aims
The cardiovascular risks associated with anabolic-androgenic steroid (AAS) use, particularly nandrolone decanoate (ND), remain a topic of debate due to conflicting evidence from different types of studies. While observational research frequently reports adverse cardiac effects...